Topic 421: building the world's first clinical oxygen imager for efficient cancer treatment
Ended Definitive Contract Awarded Last action
- Contract number
- 75N91021C00034
- Awardee
-
O2M Technologies LLC UEI RLM1GHQF3MM6
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $400,000
Award facts
- Opportunity
-
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proprosals Pre-Solicitation · PHS20211 · Posted Jul 9, 2020
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proprosals Solicitation · Posted Jul 28, 2020
- Contract value 88% obligated
-
- $400,000.00 Current, with exercised options
- $455,000.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 7 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Chicago, IL 60612, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $400,000 |
About this award
This $455,000 firm fixed price contract was awarded by the National Institutes of Health National Cancer Institute to O2M Technologies LLC, a small business, under the Small Business Innovation Research (SBIR) program. The contract is to build the world's first clinical oxygen imager for efficient cancer treatment. O2M Technologies specializes in oxygen imaging technology using pulse electron paramagnetic resonance to generate 3D pO2 maps of tissues, which provide valuable information for cancer treatment. The contract has a period of performance from September 2021 through June 2023 and is set aside for total small business participation.
Quick answers
Who was awarded contract 75N91021C00034?
75N91021C00034 was awarded to O2M Technologies LLC by National Cancer Institute (National Institutes of Health) on September 16, 2021.
How much is contract 75N91021C00034 worth?
The government has obligated $400,000 on 75N91021C00034. Its potential value, with all options, is $455,000.
Was contract 75N91021C00034 competed?
The extent of competition for 75N91021C00034 was full and open competition after exclusion of sources. The government received 7 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award